Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transient ischemic attacks and stroke.

T R Mirsen1, V C Hachinski

  • 1Department of Clinical Neurological Sciences, Faculty of Medicine, University of Western Ontario, London.

CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|June 15, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Profiles of cognitive decline in Alzheimer disease.

Alzheimer disease and associated disorders·2002
Same author

Connexin43 null mutation increases infarct size after stroke.

The Journal of comparative neurology·2001
Same author

Internal borderzone infarction: a marker for severe stenosis in patients with symptomatic internal carotid artery disease. For the North American Symptomatic Carotid Endarterectomy (NASCET) Group.

Stroke·2000
Same author

The cognitive syndrome of vascular dementia: implications for clinical trials.

Alzheimer disease and associated disorders·1999
Same author

The North American Symptomatic Carotid Endarterectomy Trial : surgical results in 1415 patients.

Stroke·1999
Same author

Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators.

The New England journal of medicine·1998

Transient ischemic attacks (TIAs) are critical stroke warnings. While carotid endarterectomy is unproven, aspirin shows efficacy, and ticlopidine is under investigation for stroke prevention.

Area of Science:

  • Neurology
  • Vascular Medicine
  • Stroke Prevention

Background:

  • Transient ischemic attacks (TIAs) are brief neurological events signaling impending stroke.
  • Recognizing and treating TIAs is crucial for stroke prevention, second only to risk factor modification.
  • Current treatments like carotid endarterectomy lack definitive proof from randomized trials.

Purpose of the Study:

  • To review the current understanding and treatment strategies for transient ischemic attacks (TIAs).
  • To evaluate the efficacy of various interventions, including surgery and antiplatelet agents, in preventing stroke after TIAs.

Main Methods:

  • Review of existing literature and randomized clinical trials concerning TIA management.
  • Analysis of the effectiveness of carotid endarterectomy, anticoagulant therapy, and antiplatelet agents like aspirin and ticlopidine.

Related Experiment Videos

Main Results:

  • Carotid endarterectomy's role in TIA treatment remains unproven, with ongoing clinical trials.
  • Anticoagulant therapy may be beneficial for TIAs caused by cardiac embolism or severe symptoms.
  • Acetylsalicylic acid (aspirin) is the only antiplatelet agent proven effective in trials, though dosage and specific populations require further study.

Conclusions:

  • Effective management of TIAs is vital for preventing future strokes.
  • Aspirin is a key treatment, but optimal use and alternatives like ticlopidine warrant further investigation.
  • Research continues to define the definitive roles of surgical and pharmacological interventions in TIA management.